Authors: Schellens, JHM Dombernowsky, P Cassidy, J Epelbaum, R Dirix, L Cox, EH Wanders, J Calabresi, F Paridaens, R Monfardini, S Wolff, J Loos, WJ Verweij, J Pavlidis, N Hanauske, AR

Citation: Jhm. Schellens et al., Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9, ANTI-CANC D, 12(7), 2001, pp. 583-590

Authors: Epelbaum, R

Citation: R. Epelbaum, Non-Hodgkin's lymphoma: long-term survivors and adverse effects, ANN ONCOL, 11, 2000, pp. 123-128

Authors: Front, D Bar-Shalom, R Mor, M Haim, N Epelbaum, R Frenkel, A Gaitini, D Kolodny, GM Israel, O

Citation: D. Front et al., Aggressive non-Hodgkin lymphoma: Early prediction of outcome with Ga-67 scintigraphy, RADIOLOGY, 214(1), 2000, pp. 253-257

Authors: Paltiel, O Schmit, T Adler, B Rachmilevitz, EA Polliack, A Cohen, A Haim, N Ben Shachar, M Epelbaum, R Barchana, M Cohen, R Ben Yehuda, D

Citation: O. Paltiel et al., The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-hodgkin lymphoma - Results and limitations of a registry-linked study, CANCER, 88(10), 2000, pp. 2357-2366

Authors: Haim, N Drumea, K Epelbaum, R Ben-Shahar, M

Citation: N. Haim et al., Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy innon-Hodgkin lymphoma, AM J CL ONC, 22(1), 1999, pp. 47-50

Authors: Front, D Bar-Shalom, R Mor, M Haim, N Epelbaum, R Frenkel, A Gaitini, D Kolodny, GM Israel, O

Citation: D. Front et al., Hodgkin disease: Prediction of outcome with Ga-67 scintigraphy after one cycle of chemotherapy, RADIOLOGY, 210(2), 1999, pp. 487-491